226 related articles for article (PubMed ID: 16683163)
1. Role of with-no-lysine [K] kinases in the pathogenesis of Gordon's syndrome.
Xie J; Craig L; Cobb MH; Huang CL
Pediatr Nephrol; 2006 Sep; 21(9):1231-6. PubMed ID: 16683163
[TBL] [Abstract][Full Text] [Related]
2. The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.
Ohta A; Schumacher FR; Mehellou Y; Johnson C; Knebel A; Macartney TJ; Wood NT; Alessi DR; Kurz T
Biochem J; 2013 Apr; 451(1):111-22. PubMed ID: 23387299
[TBL] [Abstract][Full Text] [Related]
3. Role of WNK kinases in regulating tubular salt and potassium transport and in the development of hypertension.
Gamba G
Am J Physiol Renal Physiol; 2005 Feb; 288(2):F245-52. PubMed ID: 15637347
[TBL] [Abstract][Full Text] [Related]
4. The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases.
Vitari AC; Deak M; Morrice NA; Alessi DR
Biochem J; 2005 Oct; 391(Pt 1):17-24. PubMed ID: 16083423
[TBL] [Abstract][Full Text] [Related]
5. WNK kinases and essential hypertension.
Huang CL; Kuo E; Toto RD
Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):133-7. PubMed ID: 18277144
[TBL] [Abstract][Full Text] [Related]
6. An inducible transgenic mouse model for familial hypertension with hyperkalaemia (Gordon's syndrome or pseudohypoaldosteronism type II).
Chowdhury JA; Liu CH; Zuber AM; O'Shaughnessy KM
Clin Sci (Lond); 2013 Jun; 124(12):701-8. PubMed ID: 23336180
[TBL] [Abstract][Full Text] [Related]
7. The WNKs: atypical protein kinases with pleiotropic actions.
McCormick JA; Ellison DH
Physiol Rev; 2011 Jan; 91(1):177-219. PubMed ID: 21248166
[TBL] [Abstract][Full Text] [Related]
8. Intersectin links WNK kinases to endocytosis of ROMK1.
He G; Wang HR; Huang SK; Huang CL
J Clin Invest; 2007 Apr; 117(4):1078-87. PubMed ID: 17380208
[TBL] [Abstract][Full Text] [Related]
9. WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3.
Susa K; Sohara E; Takahashi D; Okado T; Rai T; Uchida S
Biochem Biophys Res Commun; 2017 Sep; 491(3):727-732. PubMed ID: 28743496
[TBL] [Abstract][Full Text] [Related]
10. Dietary electrolyte-driven responses in the renal WNK kinase pathway in vivo.
O'Reilly M; Marshall E; Macgillivray T; Mittal M; Xue W; Kenyon CJ; Brown RW
J Am Soc Nephrol; 2006 Sep; 17(9):2402-13. PubMed ID: 16899520
[TBL] [Abstract][Full Text] [Related]
11. WNK kinases, renal ion transport and hypertension.
San-Cristobal P; de los Heros P; Ponce-Coria J; Moreno E; Gamba G
Am J Nephrol; 2008; 28(5):860-70. PubMed ID: 18547946
[TBL] [Abstract][Full Text] [Related]
12. WNK kinases and the control of blood pressure.
Cope G; Golbang A; O'Shaughnessy KM
Pharmacol Ther; 2005 May; 106(2):221-31. PubMed ID: 15866321
[TBL] [Abstract][Full Text] [Related]
13. Functional interactions of the SPAK/OSR1 kinases with their upstream activator WNK1 and downstream substrate NKCC1.
Vitari AC; Thastrup J; Rafiqi FH; Deak M; Morrice NA; Karlsson HK; Alessi DR
Biochem J; 2006 Jul; 397(1):223-31. PubMed ID: 16669787
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of type I and type II pseudohypoaldosteronism.
Furgeson SB; Linas S
J Am Soc Nephrol; 2010 Nov; 21(11):1842-5. PubMed ID: 20829405
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of disease: WNK-ing at the mechanism of salt-sensitive hypertension.
Huang CL; Kuo E
Nat Clin Pract Nephrol; 2007 Nov; 3(11):623-30. PubMed ID: 17957199
[TBL] [Abstract][Full Text] [Related]
16. Genotype-phenotype correlation in Gordon's syndrome: report of two cases carrying novel heterozygous mutations.
Anglani F; Salviati L; Cassina M; Rigato M; Gobbi L; Calò LA
J Nephrol; 2022 Apr; 35(3):859-862. PubMed ID: 34089516
[TBL] [Abstract][Full Text] [Related]
17. WNK kinases and blood pressure control.
Deaton SL; Sengupta S; Cobb MH
Curr Hypertens Rep; 2009 Dec; 11(6):421-6. PubMed ID: 19895753
[TBL] [Abstract][Full Text] [Related]
18. Structural and biochemical characterization of the KLHL3-WNK kinase interaction important in blood pressure regulation.
Schumacher FR; Sorrell FJ; Alessi DR; Bullock AN; Kurz T
Biochem J; 2014 Jun; 460(2):237-46. PubMed ID: 24641320
[TBL] [Abstract][Full Text] [Related]
19. WNK kinases regulate thiazide-sensitive Na-Cl cotransport.
Yang CL; Angell J; Mitchell R; Ellison DH
J Clin Invest; 2003 Apr; 111(7):1039-45. PubMed ID: 12671053
[TBL] [Abstract][Full Text] [Related]
20. Antagonistic regulation of ROMK by long and kidney-specific WNK1 isoforms.
Lazrak A; Liu Z; Huang CL
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1615-20. PubMed ID: 16428287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
